Review article: Associations between Helicobacter pylori and obesity - An ecological study

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 1, 2014, Pages 24-31

  Lender, N ^a,b   Talley, N J ^c   Enck, P ^d   Haag, S ^e   Zipfel, S ^d   Morrison, M ^b   Holtmann, G J ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e Gastroenterological Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BODY MASS; DEVELOPING COUNTRY; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

BODY MASS INDEX; DEVELOPED COUNTRIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OBESITY; OVERWEIGHT; PREVALENCE; WEIGHT GAIN;

EID: 84902180075     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12790     Document Type: Review

References (75)

1. Malik VS, Willett WC, Hu FB,. Global obesity: trends, risk factors and policy implications. Nature reviews. Endocrinology 2013; 9: 13-27.
2. Mascie-Taylor CG, Karim E,. The burden of chronic disease. Science 2003; 302: 1921-2.
3. Wu MS, Lee WJ, Wang HH, et al,. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 2005; 165: 1552-5.
4. Ekesbo R, Nilsson PM, Lindholm LH, et al,. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk 2000; 7: 191-5.
5. Cho I, Blaser MJ, Francois F, et al,. Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005; 162: 579-84.
6. Kamada T, Sugiu K, Haruma K,. Development of obesity and hyperlipidemia after eradication of Helicobacter pylori. Nihon Rinsho 2005; 63 (Suppl. 11): 536-8.
7. Lane JA, Murray LJ, Harvey IM, et al,. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 922-9.
8. Bassaganya-Riera J, Dominguez-Bello MG, Kronsteiner B, et al,. Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR gamma-dependent mechanism. PLoS ONE 2012; 7: e50069.
9. Boone-Heinonen J, Gordon-Larsen P, Kiefe CI, et al,. Fast food restaurants and food stores: longitudinal associations with diet in young to middle-aged adults: the CARDIA study. Arch Intern Med 2011; 171: 1162-70.
10. Zillikens MC, van Meurs JB, Rivadeneira F, et al,. SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 2009; 58: 2828-34.
11. Singh M, Kirchengast S,. Obesity prevalence and nutritional habits among Indian women: a comparison between Punjabi women living in India and Punjabi migrants in Vienna, Austria. Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur 2011; 68: 239-51.
12. Parr CL, Batty GD, Lam TH, et al,. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol 2010; 11: 741-52.
13. Agarwal AK, Jain V, Singla S, et al,. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India 2011; 59: 351-4.
14. Prentice AM,. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35: 93-9.
15. Nakajima S, Nishiyama Y, Yamaoka M, et al,. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol 2010; 25 (Suppl. 1): S99-110.
16. Yang YJ, Sheu BS, Yang HB, et al,. Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels. World J Gastroenterol 2012; 18: 2674-81.
17. McColl K, Murray L, El-Omar E, et al,. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-74.
18. Mera RM, Bravo LE, Goodman KJ, Yepez MC, Correa P,. Long-term effects of clearing Helicobacter pylori on growth in school-age children. Pediatr Infect Dis J 2012; 31: 263-6.
19. Blum AL, Talley NJ, O'Morain C, et al,. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998; 339: 1875-81.
20. Breckan RK, Paulssen EJ, Asfeldt AM, Mortensen L, Straume B, Florholmen J,. The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in Northern Norway. Scand J Gastroenterol 2009; 44: 1060-6.
21. Uchida A, Zigman JM, Perello M,. Ghrelin and eating behavior: evidence and insights from genetically-modified mouse models. Front Neurosci 2013; 7: 121.
22. Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS,. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003; 52: 637-40.
23. Francois F, Roper J, Joseph N, et al,. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. BMC Gastroenterol 2011; 11: 37.
24. Liew PL, Lee WJ, Lee YC, et al,. Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients. Obes Surg 2006; 16: 612-9.
25. Shiotani A, Miyanishi T, Uedo N, et al,. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index. Helicobacter 2005; 10: 373-8.
26. Ioannou GN, Weiss NS, Kearney DJ,. Is Helicobacter pylori seropositivity related to body mass index in the United States? Aliment Pharmacol Ther 2005; 21: 765-72.
27. Adamsson I, Nord CE, Lundquist P, et al,. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999; 44: 629-40.
28. Korpela K, Flint HJ, Johnstone AM, et al,. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS ONE 2014; 9: e90702.
29. Ley RE, Turnbaugh PJ, Klein S, et al,. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-3.
30. Buhling A, Radun D, Muller WA, et al,. Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. Aliment Pharmacol Ther 2001; 15: 1445-52.
31. Shapira Y, Poratkatz BS, Gilburd B, et al,. Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Clin Rev Allergy Immunol 2011 [Epub ahead of print].
32. Risch HA, Yu H, Lu L, et al,. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010; 102: 502-5.
33. Adamu MA, Weck MN, Rothenbacher D, et al,. Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer 2011; 128: 1652-8.
34. Peleteiro B, Lopes C, Figueiredo C, et al,. Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. Br J Cancer 2011; 104: 198-207.
35. Whiteman DC, Parmar P, Fahey P, et al,. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010; 139: 73-83.
36. Telaranta-Keerie A, Kara R, Paloheimo L, et al,. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints. Scand J Gastroenterol 2010; 45: 1036-41.
37. Sasazuki S, Inoue M, Sawada N, et al,. Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study. Carcinogenesis 2010; 31: 712-8.
38. Salomaa-Rasanen A, Kosunen TU, Aromaa AR, et al,. A "screen-and- treat" approach for Helicobacter pylori infection: a population-based study in Vammala, Finland. Helicobacter 2010; 15: 28-37.
39. Kawai T, Yamamoto K, Fukuzawa M, et al,. Helicobacter pylori infection and reflux esophagitis in young and middle-aged Japanese subjects. J Gastroenterol Hepatol 2010; 25 (Suppl. 1): S80-5.
40. Fullerton D, Britton JR, Lewis SA, et al,. Helicobacter pylori and lung function, asthma, atopy and allergic disease-a population-based cross-sectional study in adults. Int J Epidemiol 2009; 38: 419-26.
41. Moujaber T, MacIntyre CR, Backhouse J, Gidding H, Quinn H, Gilbert GL,. The seroepidemiology of Helicobacter pylori infection in Australia. Int J Infect Dis 2008; 12: 500-4.
42. Kuepper-Nybelen J, Thefeld W, Rothenbacher D, et al,. Patterns of alcohol consumption and Helicobacter pylori infection: results of a population-based study from Germany among 6545 adults. Aliment Pharmacol Ther 2005; 21: 57-64.
43. De Bastiani R, Gabrielli M, Ubaldi E, et al,. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter 2008; 13: 274-7.
44. Stettin D, Waldmann A, Wolters M, et al,. Infection with Helicobacter pylori-outcome of a cross-sectional investigation. Dtsch Med Wochenschr 2007; 132: 2677-82.
45. Sanchez Ceballos F, Taxonera Samso C, Garcia Alonso C, et al,. Prevalence of Helicobacter pylori infection in the healthy population of Madrid (Spain). Rev Esp Enferm Dig 2007; 99: 497-501.
46. Naja F, Kreiger N, Sullivan T,. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007; 21: 501-6.
47. Sharara AI, Abdul-Baki H, ElHajj I, et al,. Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes. Dig Liver Dis 2006; 38: 829-33.
48. Macenlle Garcia R, Gayoso Diz P, Sueiro Benavides RA, et al,. Prevalence of Helicobacter pylori infection in the general adult population of the province of Ourense. Rev Esp Enferm Dig 2006; 98: 241-8.
49. Cardenas VM, Mulla ZD, Ortiz M, et al,. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 2006; 163: 127-34.
50. Ang TL, Fock KM, Dhamodaran S, et al,. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population. J Gastroenterol Hepatol 2005; 20: 1603-9.
51. Simon JA, Hudes ES, Perez-Perez GI,. Relation of serum ascorbic acid to Helicobacter pylori serology in US adults: the Third National Health and Nutrition Examination Survey. J Am Coll Nutr 2003; 22: 283-9.
52. Robertson MS, Cade JF, Savoia HF, et al,. Helicobacter pylori infection in the Australian community: current prevalence and lack of association with ABO blood groups. Intern Med J 2003; 33: 163-7.
53. Nishise Y, Fukao A, Takahashi T,. Risk factors for Helicobacter pylori infection among a rural population in Japan: relation to living environment and medical history. J Epidemiol 2003; 13: 266-73.
54. Iszlai E, Kiss E, Toldy E, et al,. Seroprevalence of Helicobacter pylori infection and anti-CagA positivity in the county Szabolcs-Szatmar-Bereg. Orv Hetil 2003; 144: 1713-8.
55. Moayyedi P, Axon AT, Feltbower R, et al,. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol 2002; 31: 624-31.
56. Bode G, Hoffmeister A, Koenig W, et al,. Characteristics of differences in Helicobacter pylori serology and 13C-urea breath-testing in an asymptomatic sample of blood donors. Scand J Clin Lab Invest 2001; 61: 603-8.
57. Bazzoli F, Palli D, Zagari RM, et al,. The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors. Aliment Pharmacol Ther 2001; 15: 1001-7.
58. Rosenstock S, Jorgensen T, Andersen L, et al,. Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health 2000; 54: 444-50.
59. Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al,. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000; 181: 1359-63.
60. Russo A, Eboli M, Pizzetti P, et al,. Determinants of Helicobacter pylori seroprevalence among Italian blood donors. Eur J Gastroenterol Hepatol 1999; 11: 867-73.
61. Peach HG, Bath NE, Farish SJ,. Helicobacter pylori infection is not a correlate of plasma fibrinogen in the Australian population. Clin Lab Haematol 1999; 21: 41-3.
62. Collett JA, Burt MJ, Frampton CM, et al,. Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies. N Z Med J 1999; 112: 292-5.
63. Senra-Varela A, Lopez-Saez JB, Gomez-Biondi V,. Prevalence of Helicobacter pylori infection in two Spanish regions with different incidence of gastric cancer. Eur J Epidemiol 1998; 14: 491-4.
64. Martin de Argila C, Boixeda D, Valdezate S, et al,. ABO blood groups, rhesus factor and Helicobacter pylori. Rev Esp Enferm Dig 1998; 90: 263-8.
65. Lin SK, Lambert JR, Nicholson L, et al,. Prevalence of Helicobacter pylori in a representative Anglo-Celtic population of urban Melbourne. J Gastroenterol Hepatol 1998; 13: 505-10.
66. Dite P, Hep A, Dolina J, et al,. Prevalence of Helicobacter pylori infection in the Czech Republic-the South Moravia Region. Vnitr Lek 1998; 44: 132-4.
67. Babus V, Strnad M, Presecki V, et al,. Helicobacter pylori and gastric cancer in Croatia. Cancer Lett 1998; 125: 9-15.
68. Rodrigo Saez L, Riestra Menendez S, Fernandez Rodriguez E, et al,. Epidemiological study of the prevalence of Helicobacter pylori infection in the general population in Asturias, Spain. Rev Esp Enferm Dig 1997; 89: 511-22.
69. Murray LJ, McCrum EE, Evans AE, et al,. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemiol 1997; 26: 880-7.
70. Babus V, Presecki V, Katicic M, et al,. Distribution of Helicobacter pylori infection in the adult population of Croatia. Lijec Vjesn 1997; 119: 139-42.
71. Martin-de-Argila C, Boixeda D, Canton R, et al,. Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol 1996; 8: 1165-8.
72. Breuer T, Sudhop T, Hoch J, et al,. Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany. Eur J Gastroenterol Hepatol 1996; 8: 47-52.
73. Asaka M, Kato M, Kudo M, et al,. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol 1995; 7 (Suppl. 1): S7-10.
74. Holtmann G, Goebell H, Holtmann M, et al,. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994; 39: 1090-8.
75. Graham DY, Malaty HM, Evans DG, et al,. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-501.